Unomedical Sdn Bhd
Global medical products and technologies company focused on management of chronic conditions with leading positions in advanced wound care, ostomy care, continence care and infusion care. Operates in ~90 countries with around 10,000 employees and combines clinical development, manufacturing, regulatory and commercial activities to supply medical devices, biomaterials and digital support for long‑term care.
Industries
Nr. of Employees
Very Large (1000+)
Unomedical Sdn Bhd
Reading, Reading, United Kingdom, Europe
Patents
Products
Advanced wound care products
Dressing technologies and wound care systems including foam and hydrofiber dressings and biologic skin substitute devices for management of chronic and acute wounds.
Skin substitute and extracellular matrix devices
Biomaterial‑based skin substitute devices and tissue‑derived extracellular matrix products for wound reconstruction and burn management.
Infusion sets and connectors
Infusion sets compatible with insulin delivery platforms and other infusion delivery systems developed through partnerships and supply agreements.
Ostomy and continence care systems
Ostomy and continence devices and accessories for long‑term management of chronic conditions.
Advanced wound care products
Dressing technologies and wound care systems including foam and hydrofiber dressings and biologic skin substitute devices for management of chronic and acute wounds.
Skin substitute and extracellular matrix devices
Biomaterial‑based skin substitute devices and tissue‑derived extracellular matrix products for wound reconstruction and burn management.
Infusion sets and connectors
Infusion sets compatible with insulin delivery platforms and other infusion delivery systems developed through partnerships and supply agreements.
Ostomy and continence care systems
Ostomy and continence devices and accessories for long‑term management of chronic conditions.
Services
Manufacture and global supply of devices and consumables for wound care, ostomy, continence and infusion therapies.
Design and execution of clinical studies and randomized controlled trials to support product claims and regulatory submissions.
Patient‑facing mobile application and digital resources to support therapy adherence and user education.
Manufacture and global supply of devices and consumables for wound care, ostomy, continence and infusion therapies.
Design and execution of clinical studies and randomized controlled trials to support product claims and regulatory submissions.
Patient‑facing mobile application and digital resources to support therapy adherence and user education.
Expertise Areas
- Advanced wound care development
- Wound biologics and tissue‑derived biomaterials
- Infusion set and infusion device development
- Ostomy and continence product development
Key Technologies
- Extracellular matrix biomaterials
- Wound biologics
- Medical device regulatory pathways (510(k), CE, equivalent)
- Infusion set hardware and connector technologies
News & Updates
Announced plans to invest more than $1 billion in R&D facilities with major expansions in the US and UK.
Secured regulatory approval in the UK and Europe for a skin substitute / extracellular matrix medical device supporting treatment of hard‑to‑heal wounds.
Received U.S. regulatory clearance for a placental extracellular matrix medical device for management of second‑degree burns.
Announced plans to invest more than $1 billion in R&D facilities with major expansions in the US and UK.
Secured regulatory approval in the UK and Europe for a skin substitute / extracellular matrix medical device supporting treatment of hard‑to‑heal wounds.
Received U.S. regulatory clearance for a placental extracellular matrix medical device for management of second‑degree burns.